Clinical trial
A Study of the Zanubrutinib-containing Regimens in Patients With Newly Diagnosed Mantle Cell Lymphoma
NCT06427213 is registered in ClinicalTrials.gov with Henan Cancer Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study of the Zanubrutinib-containing Regimens in Patients With Newly Diagnosed Mantle Cell Lymphoma
- Lead sponsor
- Henan Cancer Hospital
- Phase
- Phase 2
- Overall status
- Not yet recruiting
- Start date
- May 20, 2024
- Completion date
- December 30, 2029
- Enrollment
- 41 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.